vTv Therapeutics Inc.
VTVT
$22.23
-$0.27-1.20%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 8.83% | 14.92% | -5.51% | -23.78% | -5.67% |
| Total Depreciation and Amortization | -1.11% | 0.00% | -2.17% | -1.10% | -2.17% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 54.87% | 42.76% | 99.63% | 77.40% | -41.97% |
| Change in Net Operating Assets | -223.76% | -228.63% | -45.92% | -73.15% | -18.40% |
| Cash from Operations | -32.63% | -1.51% | 19.33% | -5.37% | -19.09% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 21,071.43% | 21,071.43% |
| Total Debt Issued | -- | -100.00% | -27.06% | -27.06% | -27.06% |
| Total Debt Repaid | 68.11% | 27.23% | 27.06% | 27.06% | 25.87% |
| Issuance of Common Stock | 338.89% | 229.37% | 131.15% | 87.71% | -18.64% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 338.50% | 228.14% | 131.15% | 87.71% | -18.69% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,118.66% | 569.41% | 725.51% | 405.27% | -107.91% |